Nuvectis Pharma Inc. logo

Nuvectis Pharma Inc.

NVCT | NASDAQ
Chart Builder DCF Calculator
$21.98
-$0.02 (-0.09%)
At close: Sep 21, 2026, 4:00 PM ET
$21.98
$0 (0.00%)
After-hours: Sep 21, 2026, 4:10 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a
Operating Income
-27.57M -19.85M -22.9M -19.23M -12.89M -10K
Interest Income
1.13M 847K 637K 149K 4K n/a
Pretax Income
-26.44M -19M -22.26M -19.09M -12.89M -10K
Net Income
-26.44M -19M -22.26M -19.09M -12.89M -10K
Selling & General & Admin
9.42M 6.93M 7.52M 6.01M 3.35M 10K
Research & Development
18.15M 12.92M 15.38M 13.23M 9.55M n/a
Other Expenses
n/a n/a n/a n/a n/a n/a
Operating Expenses
27.57M 19.85M 22.9M 19.23M 12.89M 10K
Interest Expense
n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
27.57M 19.85M 22.9M 19.23M 12.89M 10K
Income Tax Expense
n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
21.81M 17.11M 15.56M 12.66M 12.72M 12.72M
Shares Outstanding (Diluted)
21.81M 17.11M 15.56M 12.66M 12.72M 12.72M
EPS (Basic)
-1.32 -1.11 -1.43 -1.51 -1.09 0
EPS (Diluted)
-1.32 -1.11 -1.43 -1.51 -1.09 0
EBITDA
-26.44M -19M -22.26M -19.09M -12.89M -10K
EBIT
-26.44M -19M -22.26M -19.09M -12.89M -10K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.